CONFERENCE PREVIEW*
A LT E R N AT I V E
PHARMA DISTRIBUTION
STRATEGIES
M AY 2 1 - 2 2 , 2 0 1 4
P H I L A D E L P H I A , PA
OPTIMIZE DECISIONS AROUND THE PRODUCTS IN YOUR PORTFOLIO
W H AT C A N Y O U E X P E C T I N 2 0 1 4 …
P R O D U C T- B A SE D A PPR OA C H
TO D I S TR IB U TION MO DE LS
• Highlighting the difference between
specialty, orphan and ultra-orphan drugs
and why successful distribution strategies
for those drugs are forced to utilize
non-traditional distribution channels
• Discussing how an evolving pipeline shapes the future of Fee-for-Service agreements
2 0 1 3 AT T E N D E E P R O F I L E
Trade & Channel 46%
Sales 19%
Specialty 14%
National Accounts 14%
Distribution 8%
A FOCUS ON HOW THE ALTERNATIVE MODELS WORK IN PRACTICE
• Analyze the viability of direct distribution
models such as direct-to-physician and
direct-to-retail models
• Discuss the advantages of distribution to
a smaller patient pool and utilizing specialty
distribution channels
PLUS TWO I N - C O N FE R E N C E
W
ORKS H O PS
THE
A Navigate Through MANUFACTURERS
the Various Direct ONLY WORKSHOP
Distribution Models
IS BACK!
B Lessons Learned from the Discount
Defendants — Re-Assess Pricing
Distribution Agreements
CONFERENCE SPONSORS:
A G RE AT P LA CE TO M E E T Y O U R M A R K E T !
Take advantage of the best opportunity to meet potential clients
face-to-face. Build relationships while demonstrating thought
leadership and sharing expertise. For more information on
how to position your company as a sponsor or exhibitor,
contact Taylor Biggers at 339-298-2108 or
email [email protected].
WWW.CBINET.COM/PHARMADISTRIBUTION
*This is preliminary conference information.
Topics, agenda and speaker names are subject to change without notice.